To provide an overview of safety culture and patient safety issues in UK emergency departments
To determine if there are any significant differences between doctors and nurses’ perception of safety issues
The survey will be undertaken in approximately 15 emergency departments within the UK, both teaching and district general hospitals.
A research nurse at each study site will randomly select 110 participants to receive a paper copy and an electronic version of the questionnaire and participant information sheet. Participants will have an option of either completing the survey online or posting the paper questionnaire back to the lead study site using a per-paid envelope. A minimum 40% response rate is required but taking part in the study is voluntary.
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.